Lataa...
Immunoassays for the quantification of ALK and phosphorylated ALK support the evaluation of on‐target ALK inhibitors in neuroblastoma
Targeted inhibition of anaplastic lymphoma kinase (ALK) is a successful approach for the treatment of many ALK‐aberrant malignancies; however, the presence of resistant mutations necessitates both the development of more potent compounds and pharmacodynamic methods with which to determine their effi...
Tallennettuna:
| Julkaisussa: | Mol Oncol |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5537911/ https://ncbi.nlm.nih.gov/pubmed/28432815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12069 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|